Back to top

View the PFP Archive

Stocks closed higher on Friday, but down for the week.
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Stocks Closed Higher On Friday, But Lower For The Week, Markets Will See Shortened Holiday Trading This Week

Stocks closed higher on Friday, but down for the week.

After Wednesday's FOMC Minutes (from October's Fed meeting, which saw them cut rates for the second time this year) showed disagreement over what to do at December's meeting, some doubt was cast on whether we'll get the expected third rate cut when they meet again in December.

But on Friday, Fed policymaker John Williams said he sees "room for further adjustment in the near term."

That boosted hopes for another cut when they meet on December 9-10. In fact, the CME's FedWatch tool puts the likelihood of a 25 basis point cut at 71.0%.

And that buoyed stocks.

But continued worries over whether we're in an AI bubble or not has been hanging over the market.

But I do not believe we are in an AI bubble.

Nor does the CEO of AI-bellwether NVIDIA think so either.

Last week, NVIDIA positively surprised on both the top and bottom lines, posting a 60.5% quarterly EPS growth rate, and a 62.5% sales growth. Astonishing numbers for such a large company, not to mention the consistency of these huge gains (10 quarters in a row of double-digit and triple-digit gains for both sales and earnings). And their upped revenue guidance for Q4 was just as astonishing. In fact, CEO Jensen Huang was quoted as saying their Q4 outlook is "crazy good."

And he dismissed talk of AI bubble fears. He said, "we're in the beginning of a very long-term buildout of the fundamental infrastructure of humanity, which is computing." "We reinvented computing for the first time in 60-70 years, and so all of the computers that have been installed around the world, is being modernized to accelerated computing and NVIDIA's GPUs and to Artificial Intelligence."

So no, I do not believe AI is in a bubble.

What we have experienced over the last few weeks is a pullback.

An ordinary pullback that happens in every bull market.

Pullbacks are defined as a decline between -5% and -9.99%, and they happen on average of 3-4 times a year.

And after 6 months of near painless gains, we were due do for a pullback.

But if you know these are commonplace moves, you can instead look at them as opportunities to buy rather than places to sell.

From their recent highs, the Dow, at its worst (Thursday's close), was off by -5.19%, the S&P was off by -5.11%, and the Nasdaq was off by -7.85%. Those numbers improved a bit on Friday with the indexes now off by 'just' -4.16%, -4.18%, and -7.18%, respectively.

A textbook definition of a pullback.

But pullbacks offer excellent opportunities to get in at better prices before the next leg up. And that's exactly what I'm expecting.

YTD, despite the pullback, the Dow is up 8.70%, the S&P is up 12.3%, and the Nasdaq is up 15.2%.

And with Q4 being the best quarter for stocks, not to mention it being a post-election year when November and December have a 72.2% and 77.8% likelihood of closing higher, I'm expecting a lot more upside to go. Especially with the backdrop of a transformational AI tech boom underway.

We've got a shortened trading week this week. Just 3½ trading days. Monday-Wednesday we have normal trading hours. But on Thursday, the markets are closed for Thanksgiving. And on Friday, we have a half-day with the markets closing early at 1:00 PM ET.

Shorter week, but should be a busy one.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

Beat Wall Street to the Trade

Med-X is preparing for a Nasdaq listing (MXRX)–but by the time the bell rings, it may be too late. Already generating $6.4M in revenue, its Nature-Cide line is sold e-commerce giants like Amazon, Walmart, and Kroger and is expanding into 41+ markets.

As regulators, consumers, and climate pressure push the $17B pest control industry natural, Med-X is positioned to lead. Right now, shares are just $4.00 through a limited Reg A+ offering.

Become a Med-X Shareholder Before Their Nasdaq Plans Unfold


Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com

Most Popular Articles from Zacks.com

Image: Bigstock

Mag 7 Earnings Outlook Improves: A Closer Look

Including Nvidia, the Mag 7 group's Q3 earnings increased +28.3% from the same period last year on +18.1% higher revenues. Read More »

Image: Bigstock

Investing in Quantum's Next Wave: IONQ, QBTS, RGTI Positioned to Win

IonQ (IONQ), D-Wave Quantum (QBTS) and Rigetti Computing (RGTI) have each signaled through earnings disclosures, customer pipeline commentary, and government-backed collaborations that quantum is steadily transitioning from promise to paid, scalable pilot. Read More »

Image: Bigstock

3 AI Infrastructure Stocks on Sale Right Now

Have you been waiting for a pullback in the AI stocks? Now is your chance. Read More »

Image: Bigstock

5 of the Cheapest Bank Stocks for 2026

Want value stocks in 2026? Look at the regional and community banks. They're cheap with bullish earnings growth expected for next year. Read More »

Image: Bigstock

Should You Hold or Fold Alibaba Stock Ahead of Q2 Earnings?

BABA surged 80.8% year to date but faces headwinds from China deflation and PDD competition. Read More »

Sponsor

America's Defense Future Starts Underground

image


A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.

See how this opportunity could strengthen America's future

Image: Bigstock

Bull of the Day: NVIDIA (NVDA)

Sentiment is way too skeptical and this is your last chance to buy the Jensen Juggernaut on sale. Read More »

New Zacks Strong Buys for November 24th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.